176 related articles for article (PubMed ID: 36984678)
21. Interactions of tamoxifen with distearoyl phosphatidylcholine multilamellar vesicles: FTIR and DSC studies.
Bilge D; Sahin I; Kazanci N; Severcan F
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():250-6. PubMed ID: 24792199
[TBL] [Abstract][Full Text] [Related]
22. Designing transmembrane alpha-helices that insert spontaneously.
Wimley WC; White SH
Biochemistry; 2000 Apr; 39(15):4432-42. PubMed ID: 10757993
[TBL] [Abstract][Full Text] [Related]
23. Electroporation of asymmetric phospholipid membranes.
Gurtovenko AA; Lyulina AS
J Phys Chem B; 2014 Aug; 118(33):9909-18. PubMed ID: 24986456
[TBL] [Abstract][Full Text] [Related]
24. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
Pandey SK; Patel DK; Maurya AK; Thakur R; Mishra DP; Vinayak M; Haldar C; Maiti P
Int J Biol Macromol; 2016 Aug; 89():99-110. PubMed ID: 27112980
[TBL] [Abstract][Full Text] [Related]
25. Voltage-dependent open-channel block of G protein-gated inward-rectifying K(+) (GIRK) current in rat atrial myocytes by tamoxifen.
Vanheiden S; Pott L; Kienitz MC
Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec; 385(12):1149-60. PubMed ID: 23096593
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
Willett MC; Dluzen DE
Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
[TBL] [Abstract][Full Text] [Related]
27. Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Müller AC; Niehoff P; Pinkawa M; Sedlmayer F; Zips D; Wiegel T;
Strahlenther Onkol; 2020 Jul; 196(7):589-597. PubMed ID: 32166452
[TBL] [Abstract][Full Text] [Related]
28. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
[TBL] [Abstract][Full Text] [Related]
29. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
30. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
Coppi G; Iannuccelli V
Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of membrane permeabilization by the peptide antibiotic surfactin.
Carrillo C; Teruel JA; Aranda FJ; Ortiz A
Biochim Biophys Acta; 2003 Apr; 1611(1-2):91-7. PubMed ID: 12659949
[TBL] [Abstract][Full Text] [Related]
32. Effect of a dirhamnolipid biosurfactant on the structure and phase behaviour of dimyristoylphosphatidylserine model membranes.
Oliva A; Teruel JA; Aranda FJ; Ortiz A
Colloids Surf B Biointerfaces; 2020 Jan; 185():110576. PubMed ID: 31670001
[TBL] [Abstract][Full Text] [Related]
33. Interfacial Dynamics in Lipid Membranes: The Effects of Headgroup Structures.
Valentine ML; Waterland MK; Fathizadeh A; Elber R; Baiz CR
J Phys Chem B; 2021 Feb; 125(5):1343-1350. PubMed ID: 33507760
[TBL] [Abstract][Full Text] [Related]
34. A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients.
Lissoni P; Ardizzoia A; Barni S; Paolorossi F; Tancini G; Meregalli S; Esposti D; Zubelewicz B; Braczowski R
Oncol Rep; 1995 Sep; 2(5):871-3. PubMed ID: 21597833
[TBL] [Abstract][Full Text] [Related]
35. Phosphatidic acid-phosphatidylethanolamine interaction and apocytochrome c translocation across model membranes.
Miao Q; Han X; Yang F
Biochem J; 2001 Mar; 354(Pt 3):681-8. PubMed ID: 11237873
[TBL] [Abstract][Full Text] [Related]
36. A DSC and FTIR spectroscopic study of the effects of the epimeric 4-cholesten-3-ols and 4-cholesten-3-one on the thermotropic phase behaviour and organization of dipalmitoylphosphatidylcholine bilayer membranes: comparison with their 5-cholesten analogues.
Benesch MG; Mannock DA; Lewis RN; McElhaney RN
Chem Phys Lipids; 2014 Jan; 177():71-90. PubMed ID: 24296232
[TBL] [Abstract][Full Text] [Related]
37. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: tamoxifen citrate.
Öztürk-Atar K; Kaplan M; Çalış S
Drug Dev Ind Pharm; 2020 Oct; 46(10):1695-1704. PubMed ID: 32893676
[TBL] [Abstract][Full Text] [Related]
39. On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice.
Caballero F; Gerez E; Oliveri L; Falcoff N; Batlle A; Vazquez E
Int J Biochem Cell Biol; 2001 Jul; 33(7):681-90. PubMed ID: 11390276
[TBL] [Abstract][Full Text] [Related]
40. Selective estrogen receptor modulation prevents scoliotic curve progression: radiologic and histomorphometric study on a bipedal C57Bl6 mice model.
Demirkiran G; Dede O; Yalcin N; Akel I; Marcucio R; Acaroglu E
Eur Spine J; 2014 Feb; 23(2):455-62. PubMed ID: 24136418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
